SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-017908
Filing Date
2020-08-14
Accepted
2020-08-14 08:30:42
Documents
50
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cbli20200630_10q.htm 10-Q 824504
2 EXHIBIT 4.3 ex_198052.htm EX-4.3 65038
3 EXHIBIT 10.3 ex_198095.htm EX-10.3 328510
4 EXHIBIT 31.1 ex_191021.htm EX-31.1 12894
5 EXHIBIT 32.1 ex_191022.htm EX-32.1 7445
  Complete submission text file 0001437749-20-017908.txt   4224766

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cbli-20200630.xml EX-101.INS 745122
7 XBRL TAXONOMY EXTENSION SCHEMA cbli-20200630.xsd EX-101.SCH 38917
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbli-20200630_cal.xml EX-101.CAL 28860
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbli-20200630_def.xml EX-101.DEF 252724
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbli-20200630_lab.xml EX-101.LAB 247196
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbli-20200630_pre.xml EX-101.PRE 275164
Mailing Address 73 HIGH STREET BUFFALO NY 14203
Business Address 73 HIGH STREET BUFFALO NY 14203 (716) 849-6810
CLEVELAND BIOLABS INC (Filer) CIK: 0001318641 (see all company filings)

IRS No.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32954 | Film No.: 201101526
SIC: 8731 Services-Commercial Physical & Biological Research